Cost-Effectiveness of Crizotinib for Second and Third-Line...

Value in Health 2018 / 05 Vol. 21

Cost-Effectiveness of Crizotinib for Second and Third-Line Treatment of Non-Small Cell Lung Cancer in Ecuador

Freire, V, Cabezas, M, Salcedo, E, Albert, A
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.04.194
Date:
May, 2018
File:
PDF, 107 KB
english, 2018
Conversion to is in progress
Conversion to is failed